Log in or Sign up for Free to view tailored content for your specialty!
Nephrology News
![Finerenone improves outcomes in patients with mildly reduced, preserved ejection fraction](/~/media/slack-news/cardiology/mugs/s/solomon_scott_david_2020_web.jpg?w=80)
Finerenone improves outcomes in patients with mildly reduced, preserved ejection fraction
In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone reduced risk for CV death and worsening HF by 16% compared with placebo, researchers reported at the European Society of Cardiology Congress.
Choice to halt RAS therapy before major surgery can be left to patient, physician
![Choice to halt RAS therapy before major surgery can be left to patient, physician](/~/media/slack-news/stock-images/pulmonology/o/oxygen-mask-surgeons_adobe.jpg?w=400)
Discontinuation of renin-angiotensin system inhibitor therapy before major noncardiac surgery did not appear to affect postoperative outcomes vs. treatment continuation, a speaker reported.
Neighborhood disadvantage linked to high rate of hypertension, low rate of treatment
![Neighborhood disadvantage linked to high rate of hypertension, low rate of treatment](/~/media/slack-news/stock-images/cardiology/d/doctor-measuring-bp_adobe-stock.jpg?w=400)
Neighborhoods with higher socioeconomic disadvantage, particularly predominantly Black areas, had higher rates of hypertension and lower rates of BP treatment vs. less disadvantaged neighborhoods, researchers reported.
Log in or Sign up for Free to view tailored content for your specialty!
Hooked on PC with Gail Guerrero-Tucker, MD, MPH, FAAFP, DABFM
![Hooked on PC with Gail Guerrero-Tucker, MD, MPH, FAAFP, DABFM](/~/media/slack-news/fm_im/misc/infographics/2024/08-august/pc0824guerrero-tucker_graphic_01_web.jpg?w=400)
Medicine was an interesting thought as I was growing up with no medical people in my family.
Fruits and vegetables ‘foundational management’ for treating hypertension
![Fruits and vegetables ‘foundational management’ for treating hypertension](/~/media/slack-news/fm_im/misc/infographics/2024/08-august/pc0824wessen_graphic_01_web2.jpg?w=400)
Dietary acid reduction from fruits and vegetables or sodium bicarbonate improved kidney health in patients with hypertension and macroalbuminuria, findings from a randomized controlled trial showed.
SGLT2 inhibitors greatly underprescribed in patients who qualify for them
![SGLT2 inhibitors greatly underprescribed in patients who qualify for them](/~/media/slack-news/endocrinology/mugs/s/shin_jungim_2020_web.jpg?w=80)
In an analysis of more than 3 million U.S. adults, most patients with a class 1a recommendation for SGLT2 inhibitors were not prescribed them, researchers reported in the Journal of the American College of Cardiology.
Top-line results: Finerenone reduces events in certain patients with heart failure
![Top-line results: Finerenone reduces events in certain patients with heart failure](/~/media/slack-news/generic-infographics/2023/generic-breaking-news.jpg?w=400)
Bayer announced positive top-line results for the FINEARTS-HF trial of finerenone, in which the drug reduced risk for cardiovascular death and heart failure events in patients with HF with preserved or mildly reduced ejection fraction.
Diabetes, weight loss drugs emerging as treatment pathway in rheumatology
![Diabetes, weight loss drugs emerging as treatment pathway in rheumatology](/~/media/slack-news/rheumatology/mugs/p/pope_janet_80x107.jpg?w=80)
Drugs used to treat diabetes and obesity, such as GLP-1 receptor agonists, are becoming an important treatment pathway in rheumatology, according to a presenter at the 2024 Association of Women in Rheumatology annual conference.
Q&A: New initiative to address CKM syndrome, affecting millions in the US
![Q&A: New initiative to address CKM syndrome, affecting millions in the US](/~/media/slack-news/cardiology/misc/infographics/2024/07_july/ct0724ndumeleqagraphic01.jpg?w=400)
In October 2023, the American Heart Association unveiled the term cardiovascular-kidney-metabolic syndrome to reflect the connection between metabolic and renal conditions associated with risk for heart disease.
Higher steroid dose improves lupus nephritis renal outcomes, raises mortality risk
![Higher steroid dose improves lupus nephritis renal outcomes, raises mortality risk](/~/media/slack-news/rheumatology/misc/infographics/2024/rheumonepager_061024.jpg?w=400)
Patients with lupus nephritis who receive higher initial doses of glucocorticoids demonstrate improved renal outcomes, albeit with increased serious infection and mortality risks, according to data published in Arthritis & Rheumatology.
-
Headline News
Mental health of health workers remains a major concern following pandemic
September 05, 20244 min read -
Headline News
How PCPs can use social drivers of health 'to affect positive change' in their communities
September 04, 20246 min read -
Headline News
QWINT: Once-weekly basal insulin noninferior to daily insulins in type 2 diabetes
September 05, 20243 min read
-
Headline News
Mental health of health workers remains a major concern following pandemic
September 05, 20244 min read -
Headline News
How PCPs can use social drivers of health 'to affect positive change' in their communities
September 04, 20246 min read -
Headline News
QWINT: Once-weekly basal insulin noninferior to daily insulins in type 2 diabetes
September 05, 20243 min read